Ou Xu
About
In The Last Decade
Ou Xu
40 papers receiving 460 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 148
- Epidemiology 119
- Infectious Diseases 113
- Cancer Research 111
- Physiology 63
Countries citing papers authored by Ou Xu
This map shows the geographic impact of Ou Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ou Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ou Xu more than expected).
Fields of papers citing papers by Ou Xu
This network shows the impact of papers produced by Ou Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ou Xu. The network helps show where Ou Xu may publish in the future.
Co-authorship network of co-authors of Ou Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ou Xu. A scholar is included among the top collaborators of Ou Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ou Xu. Ou Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 5 | |
| 9 | 21 | |
| 10 | 24 | |
| 11 | 45 | |
| 12 | LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy | 1 |
| 13 | Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study | 0 |
| 14 | 1 | |
| 15 | 5 | |
| 16 | [Expression and clinical significance of MTDH, HIF-1α and TKTL1 in laryngeal carcinoma]. | 3 |
| 17 | 17 | |
| 18 | 11 | |
| 19 | 13 | |
| 20 | 46 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.